PCI Pharma Services announced that it's investing more than $365 million in infrastructure to support assembly and packaging efforts. The investment supports the clinical- and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. PCI Pharma plans to put its investment toward new and...The post PCI Pharma Services makes $365M investment in drug delivery device manufacturing appeared first on Pharmaceutical Processing World.
PCI is a Pennsylvania-based pharma company that provides services such as drug development, clinical trials, and packaging for the pharmaceutical industry.